Curtiland Deville, MD, is the Medical Director of the Johns Hopkins Proton Therapy Center, Clinical Director of Radiation Oncology at Sibley Memorial Hospital, co-director of the Kimmel Cancer Center Prostate Multidisciplinary Clinic at Sibley Memorial Hospital and an Associate Professor at the Johns Hopkins University School of Medicine. Dr. Deville is an expert in proton therapy and a leader in several institutional and national clinical trials. He treats genitourinary malignancies, including prostate cancer, and soft tissue sarcomas, and is dedicated to creating individualized treatment plans for each patient. His research interests involve better targeting tumors through proton and photon therapies and reducing radiation to healthy tissues. He analyzes toxicity rates with modern radiation techniques and uses the most advanced technology for his patients’ care. Dr. Deville is also a Senior Editor for Advances in Radiation Oncology, as well as a reviewer for several journals that focus on radiation oncology. He is an expert on physician workforce diversity and widely published in the field. He is the immediate past Chair of the American Society of Radiation Oncology's Committee on Health Equity, Diversity and Inclusion and Chair of the American Society of Clinical Oncology’s Diversity in Oncology Subcommittee. LinkedIn https://www.linkedin.com/in/curtiland-deville-37133136. Dr. Deville is rated as an Elite provider by MediFind in the treatment of Prostate Cancer. His top areas of expertise are Prostate Cancer, Familial Prostate Cancer, Myxoid Liposarcoma, Liposarcoma, and Prostatectomy.

Dr. Channing J. Paller is a medical oncologist at Sibley Memorial Hospital and a professor of oncology at the Johns Hopkins University School of Medicine. She practices out of the Prostate Cancer Multidisciplinary Clinic at Sibley Memorial Hospital in Washington, D.C., and the Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins in Baltimore, MD. Dr. Paller has expertise in prostate, bladder, kidney, and testicular cancer. Dr. Paller earned her medical degree from Harvard Medical School and completed a residency in internal medicine, followed by a fellowship in hematology and oncology at Johns Hopkins University School of Medicine. In addition, Dr. Paller completed a rotation with the chief of the Investigational Drug Branch at the National Cancer Institute (NCI) Cancer Therapy Evaluation Program and a rotation with the associate director for regulatory science in the Office of Oncology Drug Products at the Food and Drug Administration. She also completed rotations at the Weizmann Institute of Israel’s Department of Biological Regulation and McCord Hospital in South Africa, where she participated in the Harvard AIDS project. In 2016, Dr. Paller was one of only five oncologists awarded the NCI Mentored Patient-Oriented Research Career Development Award. In 2015, she received the 2015 Passano Clinician Scientist Award for early-stage research that is already making a contribution to science. Earlier in her career, she was selected for both a 2011-2012 Young Investigator Award by the American Society of Clinical Oncology and for the 2011-12 Eastern Cooperative Oncology Group Paul Carbone Award. Dr. Paller is a member of the American Society of Clinical Oncology and the American Association for Cancer Research. Dr. Paller’s research focuses on evaluating new therapies for prostate cancer, particularly combination therapies that engage the immune system. She is the principal investigator on two multi-site clinical trials and was the first author on the NCI Investigational Drug Steering Committee publication, “Consensus Recommendations on the Phase I Combination Clinical Trials of the Clinical Trial Design Task Force.” Dr. Paller was the chair for the oral abstract session on genitourinary cancer at the 2015 Annual Meeting of the American Society of Clinical Oncology and she is currently funded by an NCI immunotherapy grant to look at combination therapies that link standard of care therapy with inhibition of transforming growth factor beta in prostate cancer. She is also opening trials of vitamin C with chemotherapy in prostate cancer and of mistletoe in all solid tumors. Dr. Paller is rated as an Elite provider by MediFind in the treatment of Prostate Cancer. Her top areas of expertise are Prostate Cancer, Familial Prostate Cancer, Muscle Invasive Bladder Cancer, Hormone Replacement Therapy (HRT), and Prostatectomy.

Ravi Madan is a Hematologist Oncology provider in Washington, Washington, D.c.. Dr. Madan is rated as an Elite provider by MediFind in the treatment of Prostate Cancer. His top areas of expertise are Prostate Cancer, Chordoma, Medullary Thyroid Carcinoma, Orchiectomy, and Prostatectomy.

Anatoly Dritschilo is a Radiation Oncologist in Washington, Washington, D.c.. Dr. Dritschilo is rated as an Elite provider by MediFind in the treatment of Prostate Cancer. His top areas of expertise are Prostate Cancer, Familial Prostate Cancer, Medulloblastoma, and Embryonal Tumor with Multilayered Rosettes.

Dr. Mark Markowski is a medical oncologist at the Kimmel Cancer Center at Sibley Memorial Hospital, as well as an Associate Professor in the Department of Oncology at Johns Hopkins University School of Medicine. Dr. Markowski participates in multidisciplinary clinics at Sibley and The Johns Hopkins Hospital, and sees patients in the genitourinary clinics of both hospitals. Dr. Markowski treats numerous types of cancers, with a specialty in prostate and kidney cancers. Dr. Markowski earned his medical degree and Ph.D. in tumor biology at Georgetown University School of Medicine. He completed a residency in internal medicine at Columbia University, followed by a medical oncology fellowship at Johns Hopkins Hospital. Dr. Markowski previously served as a research associate at the Lombardi Comprehensive Cancer Center at Georgetown University. His research interests focus on early phase drug development for prostate cancer, as well a non-castrating therapies for patients with metastatic disease. Dr. Markowski is currently conducting research with funding from a Department of Defense Prostate Cancer Research Program Award and a Challenge Award from the Prostate Cancer Foundation, which focuses on new treatment strategies for prostate cancer patients. Dr. Markowski is rated as an Elite provider by MediFind in the treatment of Prostate Cancer. His top areas of expertise are Prostate Cancer, Renal Cell Carcinoma (RCC), Wilms Tumor, Hormone Replacement Therapy (HRT), and Prostatectomy.

William Dahut is an Oncologist in Washington, Washington, D.c.. Dr. Dahut is rated as an Elite provider by MediFind in the treatment of Prostate Cancer. His top areas of expertise are Prostate Cancer, Urothelial Cancer, Bone Tumor, Prostatectomy, and Orchiectomy.

Peter Pinto is an Urologist in Bethesda, Maryland. Dr. Pinto is rated as an Elite provider by MediFind in the treatment of Prostate Cancer. His top areas of expertise are Prostate Cancer, Renal Cell Carcinoma (RCC), Enlarged Prostate (BPH), Prostatectomy, and Nephrectomy.

Jeanny Aragon-Ching is an Oncologist and a Hematologist in Alexandria, Virginia. Dr. Aragon-Ching is rated as an Elite provider by MediFind in the treatment of Prostate Cancer. Her top areas of expertise are Prostate Cancer, Urothelial Cancer, Bladder Cancer, Orchiectomy, and Prostatectomy. Dr. Aragon-Ching is currently accepting new patients.

Bradford Wood is an Interventional Radiologist in Bethesda, Maryland. Dr. Wood is rated as an Elite provider by MediFind in the treatment of Prostate Cancer. His top areas of expertise are Prostate Cancer, Liver Cancer, Enlarged Prostate (BPH), Liver Embolization, and Prostatectomy.

James Gulley is a Hematologist Oncology provider in Bethesda, Maryland. Dr. Gulley is rated as an Elite provider by MediFind in the treatment of Prostate Cancer. His top areas of expertise are Prostate Cancer, Olfactory Neuroblastoma, Chordoma, Urothelial Cancer, and Orchiectomy.

Aditya Halthore, MD, serves as Assistant Professor in the Department of Radiation Oncology and Molecular Radiation Sciences and Director of Safety and Quality at the Johns Hopkins University School of Medicine. Listen to Dr. Halthore's On Target podcast episode to learn more about his work. Dr. Halthore is an expert in proton therapy and specializes in genitourinary and thoracic cancers. His specific interests include prostate, bladder, lung, esophageal, and thymic cancers, and he is committed to developing personalized treatment strategies for every patient. Dr. Halthore was previously recognized as a Howard Hughes Medical Institute (HHMI)/National Institutes of Health (NIH) Scholar and his research interests include grant funded clinical trials focused on the novel utilization of radiation and imaging techniques, such as spatial fractionation (proton GRID) therapy for the treatment of bulky cancers. He is also involved in using dual-energy CT and functional MRI studies that aim to improve functional radiation planning and the assessment of radiation-induced changes. As an educator, Dr. Halthore serves as Course Director for the Johns Hopkins Proton Therapy Certificate Program. He actively participates in student, resident, and fellow lectureship and mentorship across the Johns Hopkins health system. Dr. Halthore participates in several national-level initiatives including as a member of the American Society of Therapeutic Radiation Oncology (ASTRO) Guidelines Subcommittee and as a board member and ASTRO liaison to the Medical Dosimetry Certification Board (MDCB). Dr. Halthore is rated as a Distinguished provider by MediFind in the treatment of Prostate Cancer. His top areas of expertise are Prostate Cancer, Small Cell Lung Cancer (SCLC), Marginal Zone Lymphoma (MZL), and Familial Prostate Cancer.

Justin O. Benabdallah, M.D., is a urologist at Sibley Memorial Hospital, as well as an assistant professor of urology with the Brady Urological Institute and Department of Urology at Johns Hopkins Medicine. Dr. Benabdallah’s uses minimally invasive and robotic surgery techniques in the treatment of prostate and kidney cancer and has expertise in endourology for the treatment of kidney stones. He also specializes in men’s health, including erectile dysfunction, male infertility, vasectomy and enlarged prostate. Dr. Benabdallah earned his medical degree from Virginia Commonwealth University School of Medicine. He completed an internship and residency in urology at the Medical College of Wisconsin. Dr. Benabdallah also completed a fellowship in endourology and minimally invasive urology at Washington University School of Medicine in St. Louis, Missouri, where he served as a clinical instructor in urology. Dr. Benabdallah is a member of the American Urologic Society and the Endourology Society. Dr. Benabdallah earned the Dr. Anna Smither Award for Neurourology Research and the Housestaff Research Award from the Medical College of Wisconsin. Dr. Benabdallah has contributed to numerous publications and presentations on topics of urology. LinkedIn https://www.linkedin.com/in/justin-benabdallah-b827b3131 Videos Justin Benabdallah, M.D. Recent News Articles and Media Coverage Physicians taking the lead during 'Movember'. Fox 6 News. 11/30/2012. Dr. Benabdallah is rated as a Distinguished provider by MediFind in the treatment of Prostate Cancer. His top areas of expertise are Familial Prostate Cancer, Prostate Cancer, UPJ Obstruction, Ureteroscopy, and Nephrectomy.

Ross Krasnow is an Urologist in Washington, Washington, D.c.. Dr. Krasnow has been practicing medicine for over 17 years and is rated as a Distinguished provider by MediFind in the treatment of Prostate Cancer. His top areas of expertise are Bladder Cancer, Muscle Invasive Bladder Cancer, WT1-Related Wilms Tumor Syndromes, Nephrectomy, and Cystectomy. Dr. Krasnow is currently accepting new patients.

Keith Kowalczyk is an Urologist in Washington, Washington, D.c.. Dr. Kowalczyk is rated as a Distinguished provider by MediFind in the treatment of Prostate Cancer. His top areas of expertise are Prostate Cancer, Renal Cell Carcinoma (RCC), Familial Prostate Cancer, Prostatectomy, and Nephrectomy. Dr. Kowalczyk is currently accepting new patients.

Jonathan Hwang is an Urologist in Washington, Washington, D.c.. Dr. Hwang is rated as a Distinguished provider by MediFind in the treatment of Prostate Cancer. His top areas of expertise are Prostate Cancer, Familial Prostate Cancer, Enlarged Prostate (BPH), Reconstructive Urology Surgery, and Vasectomy. Dr. Hwang is currently accepting new patients.

Martin Ojong-Ntui is a Radiation Oncologist in Washington, Washington, D.c.. Dr. Ojong-Ntui is rated as a Distinguished provider by MediFind in the treatment of Prostate Cancer. His top areas of expertise are Angiosarcoma, Prostate Cancer, Familial Prostate Cancer, and Breast Cancer.

Pamela Coleman is an Urologist in Washington, Washington, D.c.. Dr. Coleman is rated as a Distinguished provider by MediFind in the treatment of Prostate Cancer. Her top areas of expertise are Prostate Cancer, Familial Prostate Cancer, Enlarged Prostate (BPH), Ureteroscopy, and Prostatectomy.

Dr. Ramez I. Andrawis is a urologist affiliated with Sibley Memorial Hospital and George Washington University Hospital, where he is an assistant professor of urology and the director of the Urology Lab. He practices out of GW Medical Faculty Associates in Washington, D.C. Dr. Andrawis has an expertise in female urology, benign prostatic hyperplasia, urinary incontinence and reconstructive surgery. Dr. Andrawis earned his undergraduate and medical degree from the University of Cairo in Egypt, where he went on to complete a residency in urology. Dr. Andrawis also completed a residency in urology at the Royal College of Surgeons in Ireland, a general surgery residency at New Britain General Hospital and a urology residency at George Washington University Hospital. Dr. Andrawis has been named a Top Doctor in the Washington, D.C. and Washington-Baltimore areas by Castle Connolly. Dr. Andrawis has contributed to numerous publications on urology. Dr. Andrawis is rated as a Distinguished provider by MediFind in the treatment of Prostate Cancer. His top areas of expertise are Prostate Cancer, Familial Prostate Cancer, Enlarged Prostate (BPH), Bilateral Hydronephrosis, and Ureteroscopy.

John Lynch is an Urologist in Washington, Washington, D.c.. Dr. Lynch is rated as a Distinguished provider by MediFind in the treatment of Prostate Cancer. His top areas of expertise are Prostate Cancer, Familial Prostate Cancer, Enlarged Prostate (BPH), Prostatectomy, and Nephrectomy.

George Philips is a Hematologist Oncology specialist and a Hematologist in Washington, Washington, D.c.. Dr. Philips is rated as a Distinguished provider by MediFind in the treatment of Prostate Cancer. His top areas of expertise are Prostate Cancer, Familial Prostate Cancer, Non-Muscle Invasive Bladder Cancer, and Muscle Invasive Bladder Cancer. Dr. Philips is currently accepting new patients.